MOLN
Price
$3.72
Change
-$0.09 (-2.36%)
Updated
Apr 3, 02:38 PM (EDT)
Capitalization
134.55M
41 days until earnings call
RAPT
Price
$1.11
Change
-$0.05 (-4.31%)
Updated
Apr 3 closing price
Capitalization
147.19M
34 days until earnings call
Ad is loading...

MOLN vs RAPT

Header iconMOLN vs RAPT Comparison
Open Charts MOLN vs RAPTBanner chart's image
Molecular Partners AG
Price$3.72
Change-$0.09 (-2.36%)
Volume$400
Capitalization134.55M
RAPT Therapeutics
Price$1.11
Change-$0.05 (-4.31%)
Volume$969.1K
Capitalization147.19M
MOLN vs RAPT Comparison Chart
Loading...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MOLN vs. RAPT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MOLN is a Buy and RAPT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (MOLN: $3.72 vs. RAPT: $1.11)
Brand notoriety: MOLN and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MOLN: 64% vs. RAPT: 131%
Market capitalization -- MOLN: $134.55M vs. RAPT: $147.19M
MOLN [@Biotechnology] is valued at $134.55M. RAPT’s [@Biotechnology] market capitalization is $147.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MOLN’s FA Score shows that 0 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • MOLN’s FA Score: 0 green, 5 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, MOLN is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RAPT’s TA Score shows that 5 TA indicator(s) are bullish.

  • RAPT’s TA Score: 5 bullish, 5 bearish.

Price Growth

MOLN (@Biotechnology) experienced а -13.49% price change this week, while RAPT (@Biotechnology) price change was -21.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

MOLN is expected to report earnings on May 15, 2025.

RAPT is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPT($147M) has a higher market cap than MOLN($135M). MOLN YTD gains are higher at: -21.649 vs. RAPT (-29.747). MOLN has higher annual earnings (EBITDA): -51.65M vs. RAPT (-134.9M). RAPT has more cash in the bank: 231M vs. MOLN (149M). MOLN has less debt than RAPT: MOLN (2.44M) vs RAPT (4.49M). MOLN has higher revenues than RAPT: MOLN (4.97M) vs RAPT (0).
MOLNRAPTMOLN / RAPT
Capitalization135M147M92%
EBITDA-51.65M-134.9M38%
Gain YTD-21.649-29.74773%
P/E RatioN/AN/A-
Revenue4.97M0-
Total Cash149M231M65%
Total Debt2.44M4.49M54%
TECHNICAL ANALYSIS
Technical Analysis
RAPT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEMKX38.00N/A
N/A
Fidelity Emerging Markets Fund
GCCSX30.63N/A
N/A
Gabelli Small Cap Growth C
GICPX55.83N/A
N/A
Gabelli Global Growth AAA
YCGEX31.59N/A
N/A
YCG Enhanced
PGSLX11.05N/A
N/A
Principal Global Sus Lstd Inf Inst

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SLDB. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
-2.34%
SLDB - MOLN
36%
Loosely correlated
-7.72%
RCKT - MOLN
33%
Poorly correlated
-11.90%
ATRA - MOLN
31%
Poorly correlated
-3.43%
SNSE - MOLN
30%
Poorly correlated
-10.96%
RAPT - MOLN
30%
Poorly correlated
-3.88%
More